Connor, Clark & Lunn Investment Management (CC&L)
BLCM

Connor, Clark & Lunn Investment Management (CC&L)’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BLCM Stock Details BLCM Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,193
Closed -$147K – 985
2017
Q1 		$147K Buy
+1,193
New +$147K ﹤0.01% 827
2015
Q4 		– Sell
-1,430
Closed -$208K – 886
2015
Q3 		$208K Buy
+1,430
New +$208K ﹤0.01% 641